A Phase II Single-Arm Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Lenvatinib and TACE for Advanced Hepatocellular Carcinoma
Clinical trial NCT07150377 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07150377
- Sponsor
- The Second Affiliated Hospital of Shandong First Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-24
- Primary completion
- 2026-08-24
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.